RVTY
Revvity, Inc.
Diagnostics & Research · Healthcare · United States
117.50
close · 2026-08-13
value
83
cheaper than peers83
quality
43
stronger fundamentals43
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| price to book | 1.81× | 90 |
| forward P/E | 19.94× | 76 |
| EV to EBITDA | 17.44× | 74 |
| price to sales | 4.45× | 61 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 17.0% | 72 |
| debt to equity | 46.2% | 60 |
| return on equity | 3.2% | 48 |
| revenue growth | 1.3% | 13 |
4 of 4 measures available
Facts
| market cap | $13B |
| free cash flow | $599.4M |
| employees | 11,000 |
| first trade | 1973-02-21 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-10 |